Literature DB >> 17538807

Nail psoriasis improvement in a patient treated with fumaric acid esters.

Christina Vlachou1, John Berth-Jones.   

Abstract

Nail psoriasis is common in adult psoriatic patients and it causes serious psychological and physical distress. Topical treatments such as corticosteroids, calcipotriol, retinoids, and 5-fluorouracil have limited efficacy and are not without side effects. Relative effective systemic treatments are ciclosporin, methotrexate and acitretin, all of which have a serious toxicity potential. Biologics in the treatment of nail psoriasis have been the subject of recent research, but their cost-effectiveness is questionable. We present a case of psoriatic nail disease which improved greatly on treatment with fumaric acid esters (FAE).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17538807     DOI: 10.1080/09546630701264331

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  6 in total

1.  Nail psoriasis: clinical presentation and best practice recommendations.

Authors:  Felicity Edwards; David de Berker
Journal:  Drugs       Date:  2009       Impact factor: 9.546

2.  Fumaric acid esters in dermatology.

Authors:  Uwe Wollina
Journal:  Indian Dermatol Online J       Date:  2011-07

3.  Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy.

Authors:  Georgios Kokolakis; Frank Bachmann; Kerstin Wolk; Robert Sabat; Sandra Philipp
Journal:  Acta Derm Venereol       Date:  2020-07-28       Impact factor: 3.875

Review 4.  Nail Psoriasis: A Review of Treatment Options.

Authors:  Marcel C Pasch
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

Review 5.  Nail psoriasis: clinical features, pathogenesis, differential diagnoses, and management.

Authors:  Eckart Haneke
Journal:  Psoriasis (Auckl)       Date:  2017-10-16

Review 6.  Fumaric acid esters in the management of psoriasis.

Authors:  Deepak Mw Balak
Journal:  Psoriasis (Auckl)       Date:  2015-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.